Department of Error (DOI:10.1016/S0140-6736(07)60531-5);Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

Lancet

Volumn 369, Issue 9570, 2007, Pages 1356-1362

  Grassly, Nicholas C ^a   Wenger, Jay ^b   Durrani, Sunita ^b   Bahl, Sunil ^b   Deshpande, Jagadish M ^c   Sutter, Roland W ^d   Heymann, David L ^d   Aylward, R Bruce ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WHO   (India)

^c Enterovirus Research Centre   (India)

^d Global Polio Eradication Initiative Containment Management Group   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS 1 VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; FLACCID PARALYSIS; HUMAN; INDIA; INFECTION; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 34247094478     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60816-2     Document Type: Erratum

References (23)

1. World Health Organization. Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004. Wkly Epidemiol Rec 79 (2004) 401-408
2. World Health Organization. Progress towards global eradication of poliomyelitis, 2003 and January-April 2004. Wkly Epidemiol Rec 79 (2004) 229-236
3. World Health Organization. Progress towards poliomyelitis eradication in Egypt, January 2003 to July 2004. Wkly Epidemiol Rec 79 (2004) 316-319
4. World Health Organization. Progress towards poliomyelitis eradication in India, 2003. Wkly Epidemiol Rec 79 (2004) 121-125
5. Caceres V., and Sutter R. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 33 (2001) 531-541
6. World Health Organization. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, 11-12 October 2005. Wkly Epidemiol Rec 80 (2005) 409-416
7. Graf H. Manufacturing and supply of monovalent oral polio vaccines. Biologicals 34 (2006) 141-144
8. Aylward R., Sutter R., Cochi S., Thompson K., Jafari H., and Heymann D. Risk management in a polio-free world. Risk Anal 26 (2006) 1441-1448
9. Aylward R., Sutter R., and Heymann D. OPV cessation - the final step to a "polio-free" world. Science 310 (2005) 625-626
10. Grassly N., Fraser C., Wenger J., et al. New strategies for the elimination of polio from India. Science 314 (2006) 1150-1153
11. The World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine-a prospective evaluation in Brazil and the Gambia. J Infect Dis 171 (1995) 1097-1106
12. Posey D., Linkins R., Oliveria M., Monteiro D., and Patriarca P. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 175 (1997) S258-S263
13. Banerjee K., Hlady W., Andrus J., Sarkar S., Fitzsimmons J., and Abeykoon P. Poliomyelitis surveillance: the model used in India for polio eradication. Bull World Health Organ 78 (2000) 321-329
14. Gary Jr. H., Sanders R., and Pallansch M. A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: I. Factors affecting detection sensitivity in a person with acute flaccid paralysis. J Infect Dis 175 suppl 1 (1997) S135-S140
15. Marx A., Glass J., and Sutter R. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev 22 (2000) 298-316
16. Clayton D., and Hills M. Statistical models in epidemiology (1993), Oxford University Press, Oxford
17. Sutter R., Kew O., and Cochi S. Poliovirus vaccine-live. In: Plotkin S., and Orenstein W. (Eds). Vaccines. 4th edn. (2004), Saunders, Philadelphia, PA, USA 651-705
18. Halsey N., and Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ 63 (1985) 1151-1169
19. Kohler K., Deshpande J., Gary H., Banerjee K., Zuber P., and Hlady W. Contribution of second stool specimen to increased sensitivity of poliovirus detection in India, 1998-2000. Epidemiol Infect 131 (2003) 711-718
20. Patriarca P., Wright P., and John T. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review. Rev Infect Dis 13 (1991) 926-939
21. Henry J., Jaikaran E., Davies J., et al. A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg (Lond) 64 (1966) 105-120
22. Onorato I., Modlin J., McBean A., Thoms M., Losonsky G., and Bernier R. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 163 (1991) 1-6
23. Ghendon Y., and Sanakoyeva I. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity. Acta Virol 5 (1961) 265-273